Indiomin MB and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Indiomin MB and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Indiomin MB, ME/NaPhos/MB/Hyo1, Uro-BLUE, Urogesic-Blue, Urolet MB, UTA, UTA
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indiomin MB-Insulin degludec
- Indiomin MB-Insulin Degludec (U-100) Prefilled Pens
- Indiomin MB-Insulin Degludec (U-100) Vials
- Indiomin MB-Insulin Degludec (U-200) Prefilled Pens
- Indiomin MB-Insulin degludec and liraglutide
- Indiomin MB-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Indium 111 Oxyquinoline
- Insulin aspart, recombinant Subcutaneous-Indium DTPA
- Insulin aspart, recombinant Subcutaneous-Indium In-111 Pentetreotide
- Insulin aspart, recombinant Subcutaneous-Indium Oxyquinoline
- Insulin aspart, recombinant Subcutaneous-Indocid
- Insulin aspart, recombinant Subcutaneous-Indocin